Global Blood preparation Market is expected to reach USD 58.69 billion by
2022, according to a new study by Grand View Research, Inc. Growing worldwide
demand for transfusion of blood and its components and increasing prevalence of
blood-related disorders are expected to fuel the growth of the blood
preparation market over the forecast period. The worldwide prevalence of
thrombocytosis-associated disorders is steeply increasing. According to the
Center for Disease control and Prevention (CDC), one to two people per 1,000
are affected by DVT/PE in the U.S. each year, and 60,000-100,000 Americans die
due to DVT/PE. Commercialization of drugs currently in the pipeline,
introduction of new oral anticoagulants, and the presence of large untapped
opportunities are expected to boost product demand by triggering the incidence
rates of target diseases.
 |
Global blood preparation market share, by product, 2012 -
2022 (USD Million)
|
Anticoagulants was the largest product segment in 2014 owing to, the
increasing R&D aimed at the the development of novel prophylactic and
therapeutic drugs. Re-launch of some key drug products such as Urokinase in
North America is most likely expected to boost market growth over the forecast
period. Microbix Biosystems Inc. acquired Urokinase from Abbott Laboratories
(Abbokinase) to relaunch it as Kinelytic in the U.S. The drug is under
regulatory approval and is expected to be relaunched in the middle of 2015 in
the U.S.
In depth research report on blood preparation market
Further key
findings from the study suggest:
·
The blood
derivates market was valued at over 13.0 billion in 2014 and is expected grow
at a lucrative rate from 2015 to 2022 owing to, the increasing transfusion
needs of blood and its components. Increasing number of R&D pertaining to
the development of blood-derived medicines and expected commercialization of
new drugs are also expected to serve as high impact rendering drivers.
·
The direct
factor Xa inhibitors market is identified as the most lucrative segment on
account of the introduction of new oral products such as Xarelto, Savaysa, and
Eliquis, targeting unmet medical needs.
·
The North
American blood preparation market was the largest in 2014. The presence of
sophisticated healthcare infrastructure and high patient awareness levels
coupled with relatively higher healthcare expenditure levels in the region are
some factors attributing to its market position.
·
Asia Pacific
is anticipated to witness high future growth over the forecast period, owing to
the presence of favorable government initiatives, sophisticated healthcare
infrastructure in Japan and Australia and large untapped opportunities in the
emerging markets of China and India.
·
Key players of
the blood preparation market include GlaxoSmithKline PLC, Pfizer Inc., Baxter
Healthcare Corp., Bristol-Myers Squibb Co., Leo Pharma Inc., Sanofi Aventis,
AstraZeneca Co., and Celgene Corp.
Grand View Research has segmented the global blood preparation market on
the basis of products, anti-thrombotics and anticoagulant type, anti-thrombotics
and anticoagulant application, and region:
Global Blood preparation Market Product
Outlook (Revenue, USD Million, 2012 - 2022)
·
Whole Blood
o
Red Cells
o
Granulocytes
o
Plasma
o
Platelets
·
Blood
Components
o
Whole Blood
Components
o
Packed Red
Cells
o
Leukocyte
Reduced Red Blood Cells
o
Frozen Plasma
o
Platelet
Concentrate
o
Blood
Derivatives
Global Blood Preparation Market
Anti-Thrombotic and Anticoagulants Type Outlook (Revenue, USD Million, 2012 -
2022)
·
Platelet
Aggregation Inhibitors
o
Glycoprotein
Inhibitors
o
COX Inhibitors
o
ADP
Antagonists
o
Phosphodiesterase
Inhibitors
·
Fibrinolytics
o
Tissue
Plasminogen Activator (tPA)
o
Streptokinase
o
Urokinase
·
Anticoagulants
o
Heparins
§
Unfractionated
Heparin
§
Low Molecular
Weight Heparin (LMWH)
§
Ultra-low
Molecular Weight Heparin
o
Vitamin K
Antagonists
o
Direct
Thrombin Inhibitors
o
Direct Factor
Xa Inhibitors
Global Blood Preparation Market Anti
-Thrombotic and Anticoagulants Application Outlook (Revenue, USD Million, 2012
- 2022)
·
Thrombocytosis
·
Pulmonary
Embolism
·
Renal
Impairment
·
Others
Blood preparation Market Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
France
o
UK
o
Italy
o
Rest of Europe
·
Asia Pacific
o
Japan
o
China
·
Rest of Asia
Pacific
o
Latin America
o
Brazil
o
Mexico
·
Middle East
and Africa (MEA)
o
South Africa
Ant-ithrombotics and Anticoagulants Regional
Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
France
o
UK
o
Italy
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
Middle East
and Africa (MEA)
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment